March 24, 2026 March 24, 2026Categories News StoriesECOG-ACRIN study finds inferior survival among Black patients with AML, independent of cytogenetic risk
February 9, 2026 February 9, 2026Categories News StoriesNatasha Edwin, MD, community co-chair of the ECOG-ACRIN Myeloma Committee, highlights why patients in rural areas need access to quality clinical trials
January 29, 2026 January 29, 2026Categories News StoriesPress Release: New England Journal of Medicine publishes phase 3 PATINA (PrECOG PrE0111) trial data demonstrating a significant progression-free survival benefit with palbociclib in metastatic HR+, HER2+ breast cancer
January 21, 2026 January 21, 2026Categories News StoriesECOG-ACRIN study identifies high rates of vulnerability in AML patients aged 60 years or older
January 3, 2025 January 3, 2025Categories News StoriesA delicate balance: Treating older patients with metastatic pancreas cancer (with EA2186/GIANT trial chair Efrat Dotan)
October 30, 2024 October 30, 2024Categories News StoriesUsing the geriatric assessment to actualize goal-concordant care (with EA2186/GIANT study chair Dr. Efrat Dotan)
August 25, 2023 August 25, 2023Categories Announcements News StoriesThe July/August 2023 News from ECOG-ACRIN blog is now available
June 30, 2023 June 30, 2023Categories Announcements News StoriesThe May/June 2023 News from ECOG-ACRIN blog is now available
